Article
SEMA7AR148W mutation promotes lipid accumulation and NAFLD progression via increased localization on the hepatocyte surface.
JCI insight - 8 Aug 2022
Zhao Nan, Zhang Xiaoxun, Ding Jingjing, Pan Qiong, Zheng Ming-Hua, Liu Wen-Yue, Luo Gang, Qu Jiaquan, Li Mingqiao, Li Ling, Cheng Ying, Peng Ying, Xie Qiaoling, Wei Qinglin, Li Qiao, Zou Lingyun, Ouyang Xinshou, Cai Shi-Ying, Boyer James L, Chai Jin
Abstract excerpt
Genetic polymorphisms are associated with the development of nonalcoholic fatty liver disease (NAFLD). Semaphorin7a (Sema7a) deficiency in mouse peritoneal macrophages reduces fatty acid (FA) oxidation. Here, we identified 17 individuals with SEMA7A heterozygous mutations in 470 patients with biopsy-proven NAFLD. SEMA7A heterozygous mutations increased susceptibility to NAFLD, steatosis severity, and NAFLD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
